Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Most severe COVID-19 patients had hair loss, suggesting a possible link.

Collider bias can distort our understanding of COVID-19 risk and severity.

Collider bias can mislead our understanding of COVID-19 risk and severity.

Age, health conditions, race, and gender affect COVID-19 risk.

Older age and existing health conditions increase COVID-19 death risk.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Insulin resistance linked to obesity may increase COVID-19 severity.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Pregnant women experience similar long-term COVID-19 symptoms as the general population.

Anti-androgens might help reduce COVID-19 severity in men.

iPSCs are promising for studying and treating COVID-19.

Fungal infections are common in severe COVID-19 cases but their impact on disease severity is unclear.

Solanum nigrum shows promise for treating COVID-19 and its complications, but more research is needed.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Some alopecia treatments might help treat COVID-19, but more research is needed.

The pandemic increased concerns about skin aging, especially among women and young adults.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.